Ms. Rine has nearly 20 years of experience in clinical research. Prior to joining Fore, she spent nine years at Novartis, supporting the launches of two new molecular entities and the first commercially approved CAR-T cell therapy. Most recently, she served as the Director of Clinical Operations at Marker Therapeutics.
